Literature DB >> 9034371

Light and electron microscopic analysis of the central and peripheral nervous systems of acid sphingomyelinase-deficient mice resulting from gene targeting.

T A Kuemmel1, R Schroeder, W Stoffel.   

Abstract

The acid sphingomyelinase (aSmase)-deficient mouse line recently generated by gene targeting (Otterbach and Stoffel, 1995) develops a lethal storage disease which is phenotypically comparable to the neurovisceral form of the human sphingomyelinosis, Niemann-Pick disease type A (NPA). This report describes the progressive accumulation of uncatabolized lipid substrates at the cellular and ultrastructural level in different regions of the nervous system of homozygous aSmase-/- mice, including cerebrum, cerebellum, spinal cord, optic nerve and peripheral nerves. We saw a cytoplasmic accumulation of pleomorphic lysosomal structures in cells of all regions under study, most extensively in macrophages, vascular endothelial cells, and also in neuronal perikarya. The complete and early degeneration of Purkinje cells was particularly striking. Moreover, we found a storage material in the cytoplasm of Schwann cells and to a minor extent in oligodendrocytes. In most advanced stages of the disorder, we detected an axonal dystrophy in both the central nervous system (CNS) and peripheral nervous system (PNS), without signs of dysmyelination or demyelination. The morphological changes of the central and peripheral nervous systems in the homozygous aSmase-/- mouse line closely resemble those in human NPA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034371     DOI: 10.1097/00005072-199702000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis.

Authors:  Jingdong Qin; Evgeny Berdyshev; Jonathan Goya; Viswanathan Natarajan; Glyn Dawson
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

Review 2.  Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis.

Authors:  Maria Podbielska; Hubert Krotkiewski; Edward L Hogan
Journal:  Neurochem Res       Date:  2012-03-27       Impact factor: 3.996

3.  Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter.

Authors:  C N Hahn; M del Pilar Martin; X Y Zhou; L W Mann; A d'Azzo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

4.  Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes.

Authors:  M D Ledesma; B Brügger; C Bünning; F T Wieland; C G Dotti
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase.

Authors:  Cristian Galvan; Paola G Camoletto; Flavio Cristofani; Paul P Van Veldhoven; Maria Dolores Ledesma
Journal:  Mol Biol Cell       Date:  2007-11-21       Impact factor: 4.138

6.  Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons.

Authors:  John P Kilkus; Rajendra Goswami; Sylvia A Dawson; Fernando D Testai; Eugeny V Berdyshev; Xianlin Han; Glyn Dawson
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

7.  Lack of Acid Sphingomyelinase Induces Age-Related Retinal Degeneration.

Authors:  Bill X Wu; Jie Fan; Nicholas P Boyer; Russell W Jenkins; Yiannis Koutalos; Yusuf A Hannun; Craig E Crosson
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

8.  Synaptic vesicle docking: sphingosine regulates syntaxin1 interaction with Munc18.

Authors:  Paola G Camoletto; Hugo Vara; Laura Morando; Emma Connell; Fabio P Marletto; Maurizio Giustetto; Marco Sassoè-Pognetto; Paul P Van Veldhoven; Maria Dolores Ledesma
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.